Yukmang Disease (Korean Term for Dysentery)
Overview
Dysentery—known in Korean as yukmang disease (육망병)—is an infection of the intestine that causes severe diarrhea with blood and mucus. It is most commonly caused by certain bacteria (e.g., Shigella spp.) or parasites (e.g., Entamoeba histolytica). While the condition can affect anyone, it is especially prevalent in children, travelers, and people living in areas with poor sanitation.
- Global burden: According to the World Health Organization (WHO), bacterial dysentery accounts for an estimated 1.5 million cases of diarrheal disease each year, with the highest incidence in South‑East Asia and sub‑Saharan Africa.[1]
- Incidence in Korea: In 2022, the Korea Centers for Disease Control and Prevention (KCDC) reported ≈4,200 confirmed cases of shigellosis, the most common cause of bacterial dysentery.[2]
- Who is most affected? Children under 5, immunocompromised adults, and people who travel to endemic regions are at greatest risk.
Symptoms
Dysentery symptoms typically appear 1–7 days after exposure and can range from mild to life‑threatening. The main features are:
- Watery or bloody diarrhea: Stools may contain visible blood, mucus, or both.
- Abdominal cramps: Cramping is often colicky and may be relieved after a bowel movement.
- Fever: Low‑grade (≤38 °C) to high fever (>39 °C) may accompany infection.
- Nausea & vomiting: More common in acute bacterial dysentery.
- Urgent need to defecate: Tenesmus (feeling of incomplete evacuation).
- General malaise, fatigue, and loss of appetite.
- Dehydration signs: Dry mouth, reduced urine output, dizziness.
In Entamoeba histolytica infection (amoebic dysentery), extra‑intestinal manifestations such as liver abscesses may develop, presenting with right‑upper‑quadrant pain and fever.
Causes and Risk Factors
Primary pathogens
- Shigella spp. (shigellosis) – the leading bacterial cause worldwide.
- Salmonella enterica (certain serotypes).
- Campylobacter jejuni – can produce a dysentery‑like illness.
- Enteroinvasive Escherichia coli (EIEC).
- Entamoeba histolytica – protozoan parasite causing amoebic dysentery.
How infection occurs
- Ingestion of contaminated water or food (raw vegetables, unpasteurized dairy, undercooked meat).
- Fecal‑oral transmission via hands that have not been washed after using the toilet.
- Person‑to‑person spread in crowded settings (daycare centers, prisons, military barracks).
Risk factors
- Living in or traveling to regions with inadequate sanitation or unsafe drinking water.
- Young age (especially <5 years) due to immature immune systems.
- Immunosuppression (HIV/AIDS, chemotherapy, organ transplant).
- Use of antibiotics that disrupt normal gut flora, making colonization easier.
- Poor hand‑washing habits.
Diagnosis
Prompt diagnosis is essential to differentiate dysentery from other causes of diarrhea and to select appropriate therapy.
Clinical assessment
- History of recent travel, food intake, or exposure to sick contacts.
- Physical exam focusing on hydration status, abdominal tenderness, and presence of fever.
Laboratory tests
- Stool culture: Gold standard for bacterial pathogens (Shigella, Salmonella, Campylobacter). Samples should be collected before antibiotics are started.
- Stool ova & parasite (O&P) exam: Detects E. histolytica cysts or trophozoites.
- Polymerase chain reaction (PCR) panels: Multiplex assays rapidly identify bacterial, viral, and parasitic DNA in stool; increasingly used in high‑resource settings.
- Fecal leukocytes or lactoferrin: Presence indicates inflammatory diarrhea, supporting dysentery.
- Blood tests: CBC (often shows leukocytosis), electrolyte panel (to assess dehydration), and C‑reactive protein (CRP) for inflammation.
Imaging (rare)
If amoebic liver abscess is suspected, abdominal ultrasound or CT scan is performed.
Treatment Options
Treatment goals are to eradicate the pathogen, relieve symptoms, and prevent complications.
1. Rehydration
- Oral rehydration solution (ORS): First‑line for mild‑moderate dehydration (e.g., WHO ORS formula: 75 mEq/L Na⁺, 75 mmol/L glucose).
- Intravenous fluids: Required for severe dehydration, persistent vomiting, or hemodynamic instability.
2. Antimicrobial therapy
Antibiotics are indicated for bacterial dysentery and for severe cases of amoebic dysentery.
| Pathogen | First‑line drug | Typical dose (adult) | Duration |
|---|---|---|---|
| Shigella spp. | Ciprofloxacin | 500 mg PO BID | 3 days |
| Azithromycin (if fluoroquinolone‑resistant) | 500 mg PO daily | 3 days | |
| Salmonella (non‑typhoidal, severe) | Ceftriaxone | 2 g IV daily | 5‑7 days |
| Campylobacter | Azithromycin | 500 mg PO daily | 3 days |
| Entamoeba histolytica | Metronidazole | 750 mg PO TID | 5‑10 days |
| Follow‑up with a luminal agent (paromomycin) | 25‑35 mg/kg/day PO divided TID | 7 days |
Antibiotic resistance patterns vary by region; always refer to local antibiograms.
3. Symptomatic care
- Avoid antidiarrheal agents (e.g., loperamide) in dysentery because they may retain toxins and worsen disease.
- Antipyretics (acetaminophen or ibuprofen) for fever and discomfort.
4. Surgical intervention
Rarely required, but in fulminant colitis with perforation or toxic megacolon, emergent colectomy may be lifesaving.
Living with Yukmang Disease (Dysentery)
Even after acute illness resolves, patients may need strategies to restore gut health and prevent recurrence.
Daily management tips
- Hydration: Continue drinking ORS or clear fluids for several days after diarrhea stops.
- Probiotic support: Strains such as Lactobacillus rhamnosus GG or Saccharomyces boulardii can help re‑establish normal flora (dose per product label).[3]
- Diet: Follow the BRAT diet (bananas, rice, applesauce, toast) initially, then gradually re‑introduce fiber‑rich foods.
- Hand hygiene: Wash hands with soap for at least 20 seconds after bathroom use and before handling food.
- Monitor stool: Keep a brief log of frequency, consistency, and presence of blood; report any worsening to your clinician.
- Medication adherence: Complete the full course of prescribed antibiotics, even if you feel better.
When to see your doctor again
- Symptoms persist >7 days after starting antibiotics.
- Recurring episodes of bloody diarrhea.
- New abdominal pain, weight loss, or fever.
Prevention
Because most cases are transmitted via contaminated food or water, prevention focuses on hygiene and safe consumption practices.
- Water safety: Drink only treated, boiled, or bottled water when traveling in endemic areas.
- Food handling: Wash raw fruits/vegetables thoroughly; cook meats to internal temperatures ≥ 71 °C (160 °F).
- Hand hygiene: Soap‑and‑water washing is superior to alcohol‑based rubs for removing spores.
- Sanitation: Use latrines or toilets that separate waste from drinking water sources.
- Vaccination research: While there is no licensed vaccine for Shigella, several candidates are in phase 2 trials; keep informed of future developments.[4]
Complications
If left untreated, dysentery can lead to serious health problems.
- Severe dehydration: Electrolyte imbalance, acute kidney injury.
- Hemolytic‑uremic syndrome (HUS): Particularly after E. coli O157:H7 infection; presents with anemia, thrombocytopenia, renal failure.
- Toxic megacolon: Dilation of the colon with risk of perforation.
- Sepsis: Bacterial translocation into bloodstream.
- Chronic carrier state: Some individuals (especially Shigella carriers) may shed organisms for weeks, perpetuating outbreaks.
- Amoebic liver abscess: Occurs in 10–20 % of untreated E. histolytica infections.[5]
When to Seek Emergency Care
Immediate medical attention is required if you experience any of the following:
- Signs of severe dehydration: dry mouth, extreme thirst, little or no urine, dizziness, or rapid heartbeat.
- Bloody stools accompanied by abdominal pain that is worsening or sudden.
- High fever ≥ 39 °C (102.2 °F) that does not respond to fever reducers.
- Vomiting that prevents you from keeping fluids down.
- Confusion, lethargy, or loss of consciousness.
- Signs of shock: pale, cool skin; rapid shallow breathing; faint pulse.
- Persistent diarrhea lasting > 14 days despite treatment.
References
- World Health Organization. Diarrhoeal disease. 2023. https://www.who.int/news-room/fact-sheets/detail/diarrhoeal-disease
- Korea Centers for Disease Control and Prevention. Annual report of notifiable infectious diseases 2022. 2023.
- Institute of Medicine. Probiotics and prebiotics: health benefits and future trends. 2022.
- CDC. Shigella vaccine pipeline. 2024. https://www.cdc.gov/shigella/vaccine-pipeline.html
- National Institutes of Health. Amebiasis Treatment Guidelines. 2023. https://www.cdc.gov/parasites/amebiasis/treatment.html